Burton DR - Search Results

1

Identification and specificity of broadly neutralizing antibodies against HIV.

McCoy LE, Burton DR. McCoy LE, et al. Among authors: burton dr. Immunol Rev. 2017 Jan;275(1):11-20. doi: 10.1111/imr.12484. Immunol Rev. 2017. PMID: 28133814 Free PMC article. Review.

2

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.

Ditzel HJ, Binley JM, Moore JP, Sodroski J, Sullivan N, Sawyer LS, Hendry RM, Yang WP, Barbas CF 3rd, Burton DR. Ditzel HJ, et al. Among authors: burton dr. J Immunol. 1995 Jan 15;154(2):893-906. J Immunol. 1995. PMID: 7529290

3

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Poignard P, et al. Among authors: burton dr. Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6. Immunity. 1999. PMID: 10229186 Free article.

4

Antibodies in human infectious disease.

Parren PW, Poignard P, Ditzel HJ, Williamson RA, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Res. 2000;21(2-3):265-78. doi: 10.1385/IR:21:2-3:265. Immunol Res. 2000. PMID: 10852127 Review.

5

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

Parren PW, Moore JP, Burton DR, Sattentau QJ. Parren PW, et al. Among authors: burton dr. AIDS. 1999;13 Suppl A:S137-62. AIDS. 1999. PMID: 10885772 Review. No abstract available.

6

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. Saphire EO, et al. Among authors: burton dr. Science. 2001 Aug 10;293(5532):1155-9. doi: 10.1126/science.1061692. Science. 2001. PMID: 11498595

7

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Zwick MB, et al. Among authors: burton dr. J Virol. 2001 Nov;75(22):10892-905. doi: 10.1128/JVI.75.22.10892-10905.2001. J Virol. 2001. PMID: 11602729 Free PMC article.

8

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

Zwick MB, Wang M, Poignard P, Stiegler G, Katinger H, Burton DR, Parren PW. Zwick MB, et al. Among authors: burton dr. J Virol. 2001 Dec;75(24):12198-208. doi: 10.1128/JVI.75.24.12198-12208.2001. J Virol. 2001. PMID: 11711611 Free PMC article.

9

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.

Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Moulard M, et al. Among authors: burton dr. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. doi: 10.1073/pnas.102562599. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997472 Free PMC article.

10

Antibodies, viruses and vaccines.

Burton DR. Burton DR. Nat Rev Immunol. 2002 Sep;2(9):706-13. doi: 10.1038/nri891. Nat Rev Immunol. 2002. PMID: 12209139 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters